Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.36 |
| ▸ | HPGDS | O60760 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.33 |
| ▸ | TUBB | P07437 | 5/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.33 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28509700 | 0.79 | BRD4 (0.41) | BRD4LTA4HIMPDH2HPGDSADRA1A | |
| SCHEMBL7453756 | 0.75 | CLK4 (0.40) | BRD4 | |
| SCHEMBL1774614 | 0.73 | RAB9A (0.50) | BRD4LTA4HIMPDH2TUBB4ATUBB | |
| SCHEMBL8119348 | 0.72 | RAB9A (0.40) | IMPDH2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL5323132 | 0.72 | HPGDS (0.47) | BRD4LTA4HIMPDH2HPGDSADRA1A | |
| SCHEMBL1919495 | 0.71 | HPGDS (0.52) | BRD4LTA4HIMPDH2HPGDSADRA1A | |
| SCHEMBL5323131 | 0.71 | BRD4 (0.40) | BRD4LTA4HIMPDH2HPGDSADRA1A | |
| SCHEMBL16686010 | 0.71 | DYRK1A (0.47) | BRD4 | |
| SCHEMBL16720197 | 0.70 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL7446763 | 0.70 | NPC1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030008901-A1 | Hydroxy pipecolate hydroxamic acid derivatives | MCCLURE KIM F (US) | 2003-01-09 | — | — | US | disclosed |
| CN-1316995-A | Hydroxy 2-piperidinoate hydroxamic acid derivatives as MMP inhibitors | PFIZER PROD INC (US) | 2001-10-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008901-A1 | Hydroxy pipecolate hydroxamic acid derivatives | MMP1, MMP10, MMP3 | BRD4 3548/4885LTA4H 1084/4885IMPDH2 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.